CAPTISOL 0 200 ML APPROX 50 150 100 100150 50
Dead / Cancelled — Cancelled — Section 8 (as of 20 Feb 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86844402
- Registration number
- 5829234
- Mark type
- Design + words
- Filed
- 09 Dec 2015
- Published for opposition
- 22 Nov 2016
- Registered
- 06 Aug 2019
- Attorney of record
- Charlene A. Azema
Goods and services
- Class 001 — Chemicals: Chemical agents for use in pharmaceutical products, namely, solubilizing agents; solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; solubilization chemicals for diagnostic research; chemical additives for use as binding agents in pharmaceuticals; chemical agents used for improving stability, bioavailability and dosing of pharmaceutical ingredients
Owner
- Cydex Pharmaceuticals, Inc., San Diego, CA, US
- Cydex Pharmaceuticals, Inc., San Diego, CA, US
- Cydex Pharmaceuticals, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 20 Feb 2026 — CANCELLED SEC. 8 (6-YR)
- 06 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 02 Jul 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Jun 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Jun 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Jun 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Apr 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Apr 2019 — NON-FINAL ACTION E-MAILED
- 15 Apr 2019 — SU - NON-FINAL ACTION - WRITTEN
- 11 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Mar 2019 — USE AMENDMENT FILED
- 11 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Mar 2019 — TEAS STATEMENT OF USE RECEIVED